113 related articles for article (PubMed ID: 31957309)
1. Synthesis of Nontoxic Protoflavone Derivatives through Selective Continuous-Flow Hydrogenation of the Flavonoid B-Ring.
Ötvös SB; Vágvölgyi M; Girst G; Kuo CY; Wang HC; Fülöp F; Hunyadi A
Chempluschem; 2018 Feb; 83(2):72-76. PubMed ID: 31957309
[TBL] [Abstract][Full Text] [Related]
2. Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1'-
Vágvölgyi M; Girst G; Kúsz N; Ötvös SB; Fülöp F; Hohmann J; Servais JY; Seguin-Devaux C; Chang FR; Chen MS; Chang LK; Hunyadi A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842358
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Nontoxic Protoflavone Derivatives through Selective Continuous-Flow Hydrogenation of the Flavonoid B-Ring.
Ötvös SB; Vágvölgyi M; Girst G; Kuo CY; Wang HC; Fülöp F; Hunyadi A
Chempluschem; 2018 Feb; 83(2):71. PubMed ID: 31957310
[TBL] [Abstract][Full Text] [Related]
4. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
[TBL] [Abstract][Full Text] [Related]
5. Direct semi-synthesis of the anticancer lead-drug protoapigenone from apigenin, and synthesis of further new cytotoxic protoflavone derivatives.
Hunyadi A; Chuang DW; Danko B; Chiang MY; Lee CL; Wang HC; Wu CC; Chang FR; Wu YC
PLoS One; 2011; 6(8):e23922. PubMed ID: 21912610
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR Study of Anticancer Protoflavone Derivatives: Investigation of Cytotoxicity and Interaction with ABCB1 and ABCG2 Multidrug Efflux Transporters.
Dankó B; Tóth S; Martins A; Vágvölgyi M; Kúsz N; Molnár J; Chang FR; Wu YC; Szakács G; Hunyadi A
ChemMedChem; 2017 Jun; 12(11):850-859. PubMed ID: 28436164
[TBL] [Abstract][Full Text] [Related]
7. Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling.
Latif AD; Jernei T; Podolski-Renić A; Kuo CY; Vágvölgyi M; Girst G; Zupkó I; Develi S; Ulukaya E; Wang HC; Pešić M; Csámpai A; Hunyadi A
Antioxidants (Basel); 2020 Jun; 9(6):. PubMed ID: 32545536
[TBL] [Abstract][Full Text] [Related]
8. Highly Selective Continuous-Flow Synthesis of Potentially Bioactive Deuterated Chalcone Derivatives.
Hsieh CT; Ötvös SB; Wu YC; Mándity IM; Chang FR; Fülöp F
Chempluschem; 2015 May; 80(5):859-864. PubMed ID: 31973339
[TBL] [Abstract][Full Text] [Related]
9. Protoapigenone derivatives: albumin binding properties and effects on HepG2 cells.
Poór M; Li Y; Kunsági-Máté S; Varga Z; Hunyadi A; Dankó B; Chang FR; Wu YC; Kőszegi T
J Photochem Photobiol B; 2013 Jul; 124():20-6. PubMed ID: 23648796
[TBL] [Abstract][Full Text] [Related]
10. Cephalostatin analogues--synthesis and biological activity.
Flessner T; Jautelat R; Scholz U; Winterfeldt E
Fortschr Chem Org Naturst; 2004; 87():1-80. PubMed ID: 15079895
[TBL] [Abstract][Full Text] [Related]
11. Microbial biotransformation of bioactive flavonoids.
Cao H; Chen X; Jassbi AR; Xiao J
Biotechnol Adv; 2015; 33(1):214-223. PubMed ID: 25447420
[TBL] [Abstract][Full Text] [Related]
12. HPLC analysis, optimization of extraction and purification conditions, biological evaluation of total protoflavones from
Wei AH; Zhou DN; Gu ZC; Liu D
Nat Prod Res; 2019 Nov; 33(21):3167-3170. PubMed ID: 30449172
[TBL] [Abstract][Full Text] [Related]
13. First total synthesis of protoapigenone and its analogues as potent cytotoxic agents.
Lin AS; Nakagawa-Goto K; Chang FR; Yu D; Morris-Natschke SL; Wu CC; Chen SL; Wu YC; Lee KH
J Med Chem; 2007 Aug; 50(16):3921-7. PubMed ID: 17622129
[TBL] [Abstract][Full Text] [Related]
14. Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives.
Stanković T; Dankó B; Martins A; Dragoj M; Stojković S; Isaković A; Wang HC; Wu YC; Hunyadi A; Pešić M
Cancer Chemother Pharmacol; 2015 Sep; 76(3):555-65. PubMed ID: 26198315
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues.
Cushman M; Nagarathnam D; Burg DL; Geahlen RL
J Med Chem; 1991 Feb; 34(2):798-806. PubMed ID: 1995903
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of Icaritin and β-anhydroicaritin Mannich Base Derivatives and Their Cytotoxic Activities on Three Human Cancer Cell Lines.
Nguyen VS; Shi L; Wang SC; Wang QA
Anticancer Agents Med Chem; 2017; 17(1):137-142. PubMed ID: 27039924
[TBL] [Abstract][Full Text] [Related]
18. Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein.
Zhang S; Yang X; Coburn RA; Morris ME
Biochem Pharmacol; 2005 Aug; 70(4):627-39. PubMed ID: 15979586
[TBL] [Abstract][Full Text] [Related]
19. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo.
Chang HL; Su JH; Yeh YT; Lee YC; Chen HM; Wu YC; Yuan SS
Cancer Lett; 2008 Aug; 267(1):85-95. PubMed ID: 18430509
[TBL] [Abstract][Full Text] [Related]
20. Isolation, modification and cytotoxic evaluation of flavonoids from Rhododendron hainanense.
Zhao J; Ding HX; Zhao DG; Wang CM; Gao K
J Pharm Pharmacol; 2012 Dec; 64(12):1785-92. PubMed ID: 23146042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
